These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3712348)

  • 1. Deaths of heroin users in a general practice population.
    Bucknall AB; Robertson JR
    J R Coll Gen Pract; 1986 Mar; 36(284):120-2. PubMed ID: 3712348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between availability of heroin and methadone and fatal poisoning in England and Wales 1993-2004.
    Morgan O; Griffiths C; Hickman M
    Int J Epidemiol; 2006 Dec; 35(6):1579-85. PubMed ID: 17077102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality in heroin-assisted treatment in Switzerland 1994-2000.
    Rehm J; Frick U; Hartwig C; Gutzwiller F; Gschwend P; Uchtenhagen A
    Drug Alcohol Depend; 2005 Aug; 79(2):137-43. PubMed ID: 16002023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overdose deaths following previous non-fatal heroin overdose: record linkage of ambulance attendance and death registry data.
    Stoové MA; Dietze PM; Jolley D
    Drug Alcohol Rev; 2009 Jul; 28(4):347-52. PubMed ID: 19594787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain.
    Brugal MT; Domingo-Salvany A; Puig R; Barrio G; García de Olalla P; de la Fuente L
    Addiction; 2005 Jul; 100(7):981-9. PubMed ID: 15955014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'Topping up' methadone: an analysis of patterns of heroin use among a treatment sample of Scottish drug users.
    Bloor M; McIntosh J; McKeganey N; Robertson M
    Public Health; 2008 Oct; 122(10):1013-9. PubMed ID: 18490036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buprenorphine replacement therapy: a confirmed benefit.
    Prescrire Int; 2006 Apr; 15(82):64-70. PubMed ID: 16604748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for controlled heroin use? Low levels of negative health and social outcomes among non-treatment heroin users in Glasgow (Scotland).
    Shewan D; Dalgarno P
    Br J Health Psychol; 2005 Feb; 10(Pt 1):33-48. PubMed ID: 15826332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-fatal injuries and the use of psychoactive drugs among young adults in Spain.
    Regidor E; Barrio G; de la Fuente L; Rodríguez C
    Drug Alcohol Depend; 1996 Mar; 40(3):249-59. PubMed ID: 8861404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality rates of persons entering methadone maintenance: a seven-year study.
    Concool B; Smith H; Stimmel B
    Am J Drug Alcohol Abuse; 1979; 6(3):345-53. PubMed ID: 539576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An 1-year prospective cohort study on mortality of injecting drug users].
    Zhang L; Ruan YH; Jiang ZQ; Yang ZN; Liu SZ; Zhou F; He YX; Yin L; Qin GM; Shao YM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Mar; 26(3):190-3. PubMed ID: 15941506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suicide in farmers in Scotland.
    Stark C; Gibbs D; Hopkins P; Belbin A; Hay A; Selvaraj S
    Rural Remote Health; 2006; 6(1):509. PubMed ID: 16563050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent life problems and non-fatal overdose among heroin users entering treatment.
    Neale J; Robertson M
    Addiction; 2005 Feb; 100(2):168-75. PubMed ID: 15679746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The prevalence of human immunodeficiency virus infection and the risk behaviors in the heroin addicts of Barcelona, Madrid and Seville: an example of the advantages of centering studies on addicts and not just on intravenous users].
    de la Fuente L; Bravo MJ; Lew C; Barrio G; Soriano V; Royuela L
    Med Clin (Barc); 1999 Nov; 113(17):646-51. PubMed ID: 10618778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatal hemorrhage from legal abortion in the United States.
    Grimes DA; Kafrissen ME; O'Reilly KR; Binkin NJ
    Surg Gynecol Obstet; 1983 Nov; 157(5):461-6. PubMed ID: 6314567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi-site prospective cohort study.
    Davoli M; Bargagli AM; Perucci CA; Schifano P; Belleudi V; Hickman M; Salamina G; Diecidue R; Vigna-Taglianti F; Faggiano F;
    Addiction; 2007 Dec; 102(12):1954-9. PubMed ID: 18031430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood morphine levels in naltrexone-exposed compared to non-naltrexone-exposed fatal heroin overdoses.
    Arnold-Reed DE; Hulse GK; Hansson RC; Murray SD; O'Neil G; Basso MR; Holman CD
    Addict Biol; 2003 Sep; 8(3):343-50. PubMed ID: 13129837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts.
    Fareed A; Casarella J; Amar R; Vayalapalli S; Drexler K
    J Psychiatr Pract; 2009 May; 15(3):227-34. PubMed ID: 19461397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overdose deaths attributed to methadone and heroin in New York City, 1990-1998.
    Bryant WK; Galea S; Tracy M; Markham Piper T; Tardiff KJ; Vlahov D
    Addiction; 2004 Jul; 99(7):846-54. PubMed ID: 15200580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Narcotic-related deaths in the District of Columbia: 1971-1979.
    Zimney EL; Luke JL
    J Forensic Sci; 1981 Jul; 26(3):462-9. PubMed ID: 7252460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.